[
    [
        {
            "time": "",
            "original_text": "千亿元级市场！疫苗行业进入快速发展阶段，这家公司业绩暴增",
            "features": {
                "keywords": [
                    "疫苗",
                    "行业",
                    "快速发展",
                    "业绩暴增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "千亿元级市场！疫苗行业进入快速发展阶段，这家公司业绩暴增",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "明日最具投资机会六大牛股一览（3月20日）",
            "features": {
                "keywords": [
                    "投资机会",
                    "牛股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明日最具投资机会六大牛股一览（3月20日）",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "申万宏源：智飞生物买入评级",
            "features": {
                "keywords": [
                    "智飞生物",
                    "买入评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "申万宏源：智飞生物买入评级",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药行业周报：医疗部门体系调整 关注医药流通板块",
            "features": {
                "keywords": [
                    "医药行业",
                    "医疗部门",
                    "体系调整",
                    "医药流通"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：医疗部门体系调整 关注医药流通板块",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)年报点评：17年业绩高增长 18年HPV疫苗将迎来销售大年",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "HPV疫苗",
                    "销售大年"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)年报点评：17年业绩高增长 18年HPV疫苗将迎来销售大年",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)年报点评：一季度业绩略超预期 三联苗呈高速增长态势",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "一季度",
                    "三联苗",
                    "高速增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)年报点评：一季度业绩略超预期 三联苗呈高速增长态势",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【平安】智飞生物*300122*行业恢复+三联苗快速放量，业绩符合预期*推荐",
            "features": {
                "keywords": [
                    "智飞生物",
                    "行业恢复",
                    "三联苗",
                    "快速放量"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【平安】智飞生物*300122*行业恢复+三联苗快速放量，业绩符合预期*推荐",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)年报点评：三联苗快速放量 HPV疫苗值得期待",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "三联苗",
                    "HPV疫苗"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)年报点评：三联苗快速放量 HPV疫苗值得期待",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物2017年业绩增长超12倍 一季度净利预计2.3亿元至2.7亿元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2017年",
                    "业绩增长",
                    "一季度",
                    "净利预计"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物2017年业绩增长超12倍 一季度净利预计2.3亿元至2.7亿元",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药行业周报：国务院机构改革提升监管效率 医药行业长期趋势向好",
            "features": {
                "keywords": [
                    "医药行业",
                    "国务院",
                    "机构改革",
                    "监管效率",
                    "长期趋势向好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：国务院机构改革提升监管效率 医药行业长期趋势向好",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[买入-A评级]智飞生物(300122)年报点评：一季度业绩表现亮眼 看好公司未来业绩持续高增长及研发管线带来的价值重塑",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "一季度",
                    "业绩表现",
                    "研发管线",
                    "价值重塑"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入-A评级]智飞生物(300122)年报点评：一季度业绩表现亮眼 看好公司未来业绩持续高增长及研发管线带来的价值重塑",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]智飞生物(300122)年报点评：业绩符合预期 期待HPV继续放量",
            "features": {
                "keywords": [
                    "智飞生物",
                    "年报",
                    "业绩符合预期",
                    "HPV",
                    "放量"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]智飞生物(300122)年报点评：业绩符合预期 期待HPV继续放量",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "年报将密集披露 35家公司年报现险资身影",
            "features": {
                "keywords": [
                    "年报",
                    "险资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "年报将密集披露 35家公司年报现险资身影",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "【医药-智飞生物(300122)】江琦：公司2017年报点评：业绩实现高增长，看好2018年4价HPV疫苗销售-20180319",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2017年报",
                    "业绩高增长",
                    "4价HPV疫苗",
                    "销售"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药-智飞生物(300122)】江琦：公司2017年报点评：业绩实现高增长，看好2018年4价HPV疫苗销售-20180319",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【晨会聚焦】疫苗行业或迎投资机会",
            "features": {
                "keywords": [
                    "疫苗行业",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【晨会聚焦】疫苗行业或迎投资机会",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]